Search Results

Filter
  • 1-10 of  310 results for ""Orosomucoid""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The Orosomucoid 1 protein is involved in the vitamin D - mediated macrophage de-activation process.

  • Authors : Gemelli C; Department of Life Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41125 Modena, Italy; Center for Regenerative Medicine, University of Modena and Reggio Emilia, Via Gottardi 100, 41125 Modena, Italy. Electronic address: .

Subjects: Macrophage Activation/Macrophage Activation/Macrophage Activation/*drug effects ; Macrophages/Macrophages/Macrophages/*drug effects ; Orosomucoid/Orosomucoid/Orosomucoid/*metabolism

  • Source: Experimental cell research [Exp Cell Res] 2013 Dec 10; Vol. 319 (20), pp. 3201-13. Date of Electronic Publication: 2013 Aug 22.Publisher: Academic Press Country of Publication: United States NLM ID: 0373226 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Pro-angiogenic properties of orosomucoid (ORM).

  • Authors : Irmak S; Institute of Anatomy, University Hospital Essen, Hufelandstr. 55, D-45147 Essen, Germany.; Oliveira-Ferrer L

Subjects: Chorioallantoic Membrane/Chorioallantoic Membrane/Chorioallantoic Membrane/*metabolism ; Endothelium, Vascular/Endothelium, Vascular/Endothelium, Vascular/*metabolism ; Neovascularization, Physiologic/Neovascularization, Physiologic/Neovascularization, Physiologic/*physiology

  • Source: Experimental cell research [Exp Cell Res] 2009 Nov 01; Vol. 315 (18), pp. 3201-9. Date of Electronic Publication: 2009 Aug 03.Publisher: Academic Press Country of Publication: United States NLM ID: 0373226 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Modulation of the blood-brain barrier permeability by plasma glycoprotein orosomucoid.

  • Authors : Yuan W; Department of Biomedical Engineering, The City College of the City University of New York, New York, NY 10031, USA.; Li G

Subjects: Blood-Brain Barrier/Blood-Brain Barrier/Blood-Brain Barrier/*drug effects ; Capillary Permeability/Capillary Permeability/Capillary Permeability/*drug effects ; Orosomucoid/Orosomucoid/Orosomucoid/*pharmacology

  • Source: Microvascular research [Microvasc Res] 2010 Jul; Vol. 80 (1), pp. 148-57. Date of Electronic Publication: 2010 Apr 01.Publisher: Academic Press Country of Publication: United States NLM ID: 0165035 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity.

  • Authors : Smith EMD; Department of Women's & Children's Health, University of Liverpool, Liverpool, UK; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK. Electronic address: .

Subjects: Markov Chains*; Ceruloplasmin/Ceruloplasmin/Ceruloplasmin/*urine ; Lupus Nephritis/Lupus Nephritis/Lupus Nephritis/*diagnosis

  • Source: Clinical immunology (Orlando, Fla.) [Clin Immunol] 2019 Jan; Vol. 198, pp. 71-78. Date of Electronic Publication: 2018 Nov 02.Publisher: Academic Press Country of Publication: United States NLM ID: 100883537 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Temperature controlled ionic liquid aqueous two phase system combined with affinity capillary electrophoresis for rapid and precise pharmaceutical-protein binding measurements.

  • Authors : Abd El-Hady D; Chemistry Department, Faculty of Science, University of Jeddah, P.O. 80327, 21589 Jeddah, Saudi Arabia. Electronic address: .; Albishri HM

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*chemistry ; Electrophoresis, Capillary/Electrophoresis, Capillary/Electrophoresis, Capillary/*methods ; Orosomucoid/Orosomucoid/Orosomucoid/*chemistry

  • Source: Methods (San Diego, Calif.) [Methods] 2018 Aug 15; Vol. 146, pp. 120-125. Date of Electronic Publication: 2018 Feb 10.Publisher: Academic Press Country of Publication: United States NLM ID: 9426302 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Alpha1-acid-glycoprotein protects against trauma-hemorrhagic shock.

  • Authors : Kuebler JF; Center for Surgical Research and Department of Surgery, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 35294-0019, USA.; Toth B

Subjects: Orosomucoid/Orosomucoid/Orosomucoid/*therapeutic use ; Shock, Hemorrhagic/Shock, Hemorrhagic/Shock, Hemorrhagic/*prevention & control ; Wounds and Injuries/Wounds and Injuries/Wounds and Injuries/*drug therapy

  • Source: The Journal of surgical research [J Surg Res] 2004 Jun 01; Vol. 119 (1), pp. 21-8.Publisher: Academic Press Country of Publication: United States NLM ID: 0376340 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Purification and characterization of two recombinant human glucuronyltransferases involved in the biosynthesis of HNK-1 carbohydrate in Escherichia coli.

  • Authors : Kakuda S; Department of Biological Chemistry, Kyoto University, Kyoto 606-8501, Japan.; Oka S

Subjects: CD57 Antigens/CD57 Antigens/CD57 Antigens/*biosynthesis ; Escherichia coli/Escherichia coli/Escherichia coli/*metabolism ; Glucuronosyltransferase/Glucuronosyltransferase/Glucuronosyltransferase/*metabolism

  • Source: Protein expression and purification [Protein Expr Purif] 2004 May; Vol. 35 (1), pp. 111-9.Publisher: Academic Press Country of Publication: United States NLM ID: 9101496 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.

  • Authors : le Coutre P; Abteilung für Hämatologie und Onkologie, Campus Virchow, Charité, Humboldt Universität, Berlin, Germany. ; Kreuzer KA

Subjects: Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*drug therapy ; Orosomucoid/Orosomucoid/Orosomucoid/*metabolism ; Piperazines/Piperazines/Piperazines/*pharmacology

  • Source: Blood cells, molecules & diseases [Blood Cells Mol Dis] 2002 Jan-Feb; Vol. 28 (1), pp. 75-85.Publisher: Academic Press Country of Publication: United States NLM ID: 9509932 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

An inhibitory effect of a protein kinase inhibitor, staurosporine, on delivery of endocytosed asialoglycoprotein to lysosome in monolayer culture of rat hepatocytes.

  • Authors : Ohashi M; Department of Biophysics, Faculty of Science, Kyoto University, Japan.; Ohnishi S

Subjects: Asialoglycoproteins* ; Protein Kinase Inhibitors*; Alkaloids/Alkaloids/Alkaloids/*pharmacology

  • Source: Experimental cell research [Exp Cell Res] 1991 Dec; Vol. 197 (2), pp. 168-75.Publisher: Academic Press Country of Publication: United States NLM ID: 0373226 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Low concentrations of primaquine inhibit degradation but not receptor-mediated endocytosis of asialoorosomucoid by HepG2 cells.

  • Authors : Reif JS; Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri 63110.; Schwartz AL

Subjects: Asialoglycoproteins/Asialoglycoproteins/Asialoglycoproteins/*metabolism ; Liver/Liver/Liver/*metabolism ; Orosomucoid/Orosomucoid/Orosomucoid/*analogs & derivatives

  • Source: Experimental cell research [Exp Cell Res] 1991 Feb; Vol. 192 (2), pp. 581-6.Publisher: Academic Press Country of Publication: United States NLM ID: 0373226 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  310 results for ""Orosomucoid""